Furthermore, the BRAF alteration is often associated with mutations of PTEN, an inhibitor of the PI3 kinase/Akt1 pathways [50], which in turn causes an increased activation of PI3K/Akt1 and can further enhance melanoma progression. This evidence concerns the gene BRAF and melanoma.